H. Lundbeck AS 2024 AR2
The report highlights H. Lundbeck A/S's transformative year in 2024, marked by achieving its highest-ever revenue of DKK 22,004 million, driven by a 21% growth in strategic brands. The company launched its Focused Innovator Strategy and completed the strategic acquisition of Longboard Pharmaceuticals to enhance its neuro-rare disease franchise. In sustainability, Lundbeck published its first integrated annual report in accordance with the CSRD, achieving a 38% reduction in Scope 1 and 2 emissions since 2019 and reaching 7.2 million patients globally. However, Scope 3 emissions increased by 18%, and certain circularity and safety targets were not met.
Company: H. Lundbeck AS
Sector: Health Care
Country: Denmark
Year: 2024
Type: AR2
Pages: 228
H. Lundbeck AS
Annual Report
The report highlights H. Lundbeck A/S's transformative year in 2024, marked by achieving its highest-ever revenue of DKK 22,004 million, driven by a 21% growth in strategic brands. The company launched its Focused Innovator Strategy and completed the strategic acquisition of Longboard Pharmaceuticals to enhance its neuro-rare disease franchise. In sustainability, Lundbeck published its first integrated annual report in accordance with the CSRD, achieving a 38% reduction in Scope 1 and 2 emissions since 2019 and reaching 7.2 million patients globally. However, Scope 3 emissions increased by 18%, and certain circularity and safety targets were not met.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees